Company video

Cerbios own and manufactures the strain Enterococcus lactis SF68 applied in different therapeutic areas:

- Diarrhea, travellers diarrhea and dysbiosis: drug with 20 clinical trials, CTD dossier and registration from Switzerland (for extra EU Countries)


- Acne & Seborrheic dermatitis
- Obesity/Cholesterol and metabiolic syndrome
- IBS
- Immunity Booster


Any product is supported by precilical and clinical evidences.


Cerbios business model if B2B, searching for commercial Licensees worldwide

Cerbios is highly qualified in process development of new APIs and HPAPIs for preclinical, clinical and commercial supply. Cerbios is the ideal and reliable partner for your New Chemical Entity (NCE), NDA submission and commercial manufacturing.

From cloning to cGMP production, Cerbios meets your product development and manufacturing needs for recombinant proteins, monoclonal antibodies (mAbs) and novel mAbs derivatives including fragments and Bispecific.

Offered Services: Process and Analytical Development cGMP Manufacturing in the Fully Integrated site of Lugano Complete Regulatory Documentation for IND submission and NDA Commercial Supply